United Kingdom (UK) Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Summary
Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The UK biotechnology market had total revenues of $20.5 billion in 2021, representing a compound annual growth rate (CAGR) of 16.9% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $13.5 billion, equivalent to 66% of the market's overall value.
- As in many other developed countries, the UK’s aging population is driving demand in the medical/healthcare segment as more people suffer from long-term chronic diseases. Biotech plays an important role here.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts by both value and volume
- What was the size of the United Kingdom biotechnology market by value in 2021?
- What will be the size of the United Kingdom biotechnology market in 2026?
- What factors are affecting the strength of competition in the United Kingdom biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in the United Kingdom's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the strengths of leading players?
- 7.4. What has been the rationale behind recent M&A activity?
- 8 Company Profiles
- 8.1. AstraZeneca PLC
- 8.2. Novartis AG
- 8.3. GE Healthcare
- 8.4. GSK plc.
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: United Kingdom biotechnology industry value: $ billion, 2016–21
- Table 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2016–2021
- Table 3: United Kingdom biotechnology industry category segmentation: $ billion, 2016-2021
- Table 4: United Kingdom biotechnology industry geography segmentation: $ billion, 2021
- Table 5: United Kingdom biotechnology industry value forecast: $ billion, 2021–26
- Table 6: AstraZeneca PLC: key facts
- Table 7: AstraZeneca PLC: Annual Financial Ratios
- Table 8: AstraZeneca PLC: Key Employees
- Table 9: Novartis AG: key facts
- Table 10: Novartis AG: Annual Financial Ratios
- Table 11: Novartis AG: Key Employees
- Table 12: Novartis AG: Key Employees Continued
- Table 13: GE Healthcare: key facts
- Table 14: GE Healthcare: Key Employees
- Table 15: GE Healthcare: Key Employees Continued
- Table 16: GSK plc.: key facts
- Table 17: GSK plc.: Annual Financial Ratios
- Table 18: GSK plc.: Key Employees
- Table 19: GSK plc.: Key Employees Continued
- Table 20: United Kingdom size of population (million), 2017–21
- Table 21: United Kingdom gdp (constant 2005 prices, $ billion), 2017–21
- Table 22: United Kingdom gdp (current prices, $ billion), 2017–21
- Table 23: United Kingdom inflation, 2017–21
- Table 24: United Kingdom consumer price index (absolute), 2017–21
- Table 25: United Kingdom exchange rate, 2017–21
- List of Figures
- Figure 1: United Kingdom biotechnology industry value: $ billion, 2016–21
- Figure 2: United Kingdom biotechnology industry category segmentation: $ billion, 2016-2021
- Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2021
- Figure 4: United Kingdom biotechnology industry value forecast: $ billion, 2021–26
- Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2021
- Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2021
- Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2021
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2021
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2021
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook